Symposium —Tumour Heterogeneity and Stratified Medicine
23/09/2014 - 24/09/2014, 11:00 - 15:00
The European Cancer Stem Cell Research Institute is hosting a FREE research symposium dedicated to the theme of Tumour Heterogeneity and Stratified Medicine. This is a two-day event commencing at 11.00 on 23rd September and ending with lunch at 14.00 on 24th September.
DAY 1: 23 September
- Professor Xin Lu (Ludwig Institute for Cancer Research) Cell Polarity and Epithelium Cell Plasticity in Tumour Suppression
- Professor Mel Greaves FRS (The Institute of Cancer Research) Evolutionary principles of diversity and selection (and the role of stem cells) in cancer
- Dr Trevor Graham (Barts Cancer Institute, QMUL) Recent insights into the clonal evolution of human colorectal cancer
- Professor Tim Maughan (Cancer Research UK/MRC Oxford Institute for Radiation Oncology) Title to be confirmed
- Dr Nick Barker (Institute of Medical Biology) Lgr5 stem cells in Epithelial Homeostasis and Regeneration
- Dr Patrizia Cammareri (Beatson Institute for Cancer Research) 3D organoids as a powerful tool for studying intestinal tumorigenesis
- Dr Merixtell Huch (Gurdon Institute, University of Cambridge) Lgr5 liver stem cells, hepatic organoids and regenerative medicine
- Professor Inke Nathke (University of Dundee) Linking stem cell division and tissue organisation
- Dr Neil Rodrigues (The European Cancer Stem Cell Research Institute, Cardiff University) Title to be confirmed
DAY 2: 24 September
- Dr Douglas Winton (Cancer Research UK Cambridge Institute) Fate and Fitness of intestinal stem cell after oncogenic transformation
- Professor Pier Paolo di Fiore (IFOM Foundation (Milan), European Institute of Oncology (Milan) and University of Milan) Title to be confirmed
- Dr Phil Jones (University of Cambridge) Cell dynamics in oesophageal carcinogenesis
- Dr Richard Clarkson (The European Cancer Stem Cell Research Institute, Cardiff University) Preventing plasticity of breast cancer stem cells
- Dr Vivian Li (National Institute for Medical Research) Regulation of intestinal stem cells – tissue homeostasis and cancer
- Dr Kim Jensen (University of Copenhagen) Linking tumour heterogeneity to the cell of origin
- Professor Kamil Kranc (MRC Centre for Regenerative Medicine, University of Edinburgh) The quest for regulatory pathways of normal and leukaemic stem cell functions
- Dr Bon-Kyoung Koo (WT-MRC Cambridge Stem Cell Institute, University of Cambridge) Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors
- Dr Matt Smalley (The European Cancer Stem Cell Research Institute, Cardiff University) Title to be confirmed
Cost: FREE (delegates to organise and cover costs of own transport and accommodation).
Open To: Public, Staff and Postgraduate students.
Disabled access: Yes
Booking required.Book places
Save this event to your calendar of choice.